Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Permitted Daily Exposure (PDE) Values for Active Pharmaceutical Ingredients (APIs) - Evidence of Robust Approach.
Sehner C, Bernier T, Blum K, Clemann N, Glogovac M, Hawkins WA, Kohan M, Linker F, Lovsin-Barle E, Osadolor O, Pfister T, Schulze E, Schwind M, Tuschl G, Wiesner L. Sehner C, et al. Among authors: pfister t. Regul Toxicol Pharmacol. 2024 May 21:105649. doi: 10.1016/j.yrtph.2024.105649. Online ahead of print. Regul Toxicol Pharmacol. 2024. PMID: 38782234
Drug safety in older patients with alcohol use disorder: a retrospective cohort study.
Schröder S, Westhoff MS, Pfister T, Seifert J, Bleich S, Koop F, Proskynitopoulos PJ, Glahn A, Heck J. Schröder S, et al. Among authors: pfister t. Ther Adv Psychopharmacol. 2024 Feb 21;14:20451253241232563. doi: 10.1177/20451253241232563. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 38384595 Free PMC article.
Preinterventional Third-Molar Assessment Using Robust Machine Learning.
Carvalho JS, Lotz M, Rubi L, Unger S, Pfister T, Buhmann JM, Stadlinger B. Carvalho JS, et al. Among authors: pfister t. J Dent Res. 2023 Dec;102(13):1452-1459. doi: 10.1177/00220345231200786. Epub 2023 Nov 9. J Dent Res. 2023. PMID: 37944556 Free PMC article.
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.
Salawu A, Wang BX, Han M, Geady C, Heirali A, Berman HK, Pfister TD, Hernando-Calvo A, Al-Ezzi EM, Stayner LA, Gupta AA, Ayodele O, Lam B, Hansen AR, Spreafico A, Bedard PL, Butler MO, Avery L, Coburn B, Haibe-Kains B, Siu LL, Abdul Razak AR. Salawu A, et al. Among authors: pfister td. Clin Cancer Res. 2023 Oct 13;29(20):4128-4138. doi: 10.1158/1078-0432.CCR-23-1137. Clin Cancer Res. 2023. PMID: 37566240
120 results